Momenta Pharmaceuticalsincis A Biotechnology Company Based In Cambridgemassachusettsfounded In 2001The Company Specializes In The Structural Analysis And Engineering Of Complex Sugars And Glycosylated Biomoleculesit Utilizes Proprietary Technology To Develop Novel Therapeuticsbiosimilarsand Improved Versions Of Existing Drugsmomenta S Platform Supports High Throughput Sequencing And Precise Characterization Of Glycoproteinswith A Focus On Applications In Cardiovascular Diseaseoncologyand Non Invasive Drug Delivery The Company Is Dedicated To Therapeutic Developmentparticularly For Rare Immune Mediated Diseases And Biologicsits Pipeline Includes Novel Drug Candidates And Advanced Late Stage Biosimilar Programsmomenta S Proprietary Technology Enables The Analysis And Modification Of Complex Sugar Structuresoptimizing Drug Efficacy And Safetythe Company Has Made Significant Strides In Intellectual Propertyholding 206 Patents Related To Cell Culture Processesimmunologyand Glycoprotein Engineeringin August 2020Momenta Was Acquired By Johnson & Johnsonfurther Enhancing Its Position In The Biopharmaceutical Market
No conferences found for this company.
| Company Name | Momenta Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
